(WTW) Willis Towers Watson - Ratings and Ratios
Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: IE00BDB6Q211
WTW: Insurance, Consulting, Broking, Services, Solutions, Software
Willis Towers Watson PLC, trading under the ticker WTW on NASDAQ, stands as a global powerhouse in advisory, broking, and solutions. With roots tracing back to 1828, this firm has evolved into a key player in the insurance and consulting sectors. Its dual segments—Health, Wealth & Career and Risk & Broking—underscore its comprehensive approach to serving clients across various industries.
The Health, Wealth & Career segment offers a suite of services designed to optimize employee benefits and retirement plans. From strategy consulting to plan management, WTW helps organizations enhance their health and wellbeing programs, including medical, dental, and life insurance. Their expertise extends to retirement consulting, ensuring pension and savings plans are both sustainable and aligned with organizational goals.
The Risk & Broking segment is where WTWs insurance brokerage and risk management capabilities shine. They cater to diverse sectors such as property and casualty, aerospace, and natural resources, providing tailored solutions to mitigate risks. Their services encompass everything from risk assessment to crisis management, underpinned by data-driven insights and advanced analytics.
WTWs commitment to innovation is evident in their integration of technology. They leverage software solutions to enhance risk and capital management, offering tools for financial modeling and regulatory reporting. This blend of human expertise and technological prowess positions them as a forward-thinking leader in their field.
For investors, WTWs market cap of over $32 billion and a forward P/E of 17.86 indicate a stable yet growth-oriented company. Their price-to-sales ratio of 3.33 suggests a premium valuation, reflecting their strong market position and diverse service offerings. This makes WTW an attractive consideration for those seeking exposure to the insurance and consulting sectors with a global reach and a history of resilience.
Additional Sources for WTW Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WTW Stock Overview
Market Cap in USD | 32,987m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception | 2016-01-05 |
WTW Stock Ratings
Growth 5y | 74.2% |
Fundamental | 25.3% |
Dividend | 57.2% |
Rel. Strength Industry | 3.11 |
Analysts | 3.95/5 |
Fair Price Momentum | 353.57 USD |
Fair Price DCF | 350.46 USD |
WTW Dividends
Dividend Yield 12m | 1.14% |
Yield on Cost 5y | 2.18% |
Annual Growth 5y | 5.06% |
Payout Consistency | 97.4% |
WTW Growth Ratios
Growth Correlation 3m | 84.6% |
Growth Correlation 12m | 91.3% |
Growth Correlation 5y | 78.7% |
CAGR 5y | 14.21% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | 0.92 |
Alpha | 16.63 |
Beta | 0.12 |
Volatility | 21.59% |
Current Volume | 566.6k |
Average Volume 20d | 563.8k |
As of March 12, 2025, the stock is trading at USD 326.52 with a total of 566,567 shares traded.
Over the past week, the price has changed by -2.46%, over one month by +2.10%, over three months by +8.22% and over the past year by +23.59%.
Neither. Based on ValueRay Fundamental Analyses, Willis Towers Watson is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.32 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WTW as of March 2025 is 353.57. This means that WTW is currently overvalued and has a potential downside of 8.28%.
Willis Towers Watson has received a consensus analysts rating of 3.95. Therefor, it is recommend to buy WTW.
- Strong Buy: 7
- Buy: 5
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, WTW Willis Towers Watson will be worth about 381.9 in March 2026. The stock is currently trading at 326.52. This means that the stock has a potential upside of +16.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 361.8 | 10.8% |
Analysts Target Price | 360.3 | 10.3% |
ValueRay Target Price | 381.9 | 16.9% |